nodes	percent_of_prediction	percent_of_DWPC	metapath
Flumazenil—Salivation—Irinotecan—colon cancer	0.0349	0.0349	CcSEcCtD
Flumazenil—Panic attack—Capecitabine—colon cancer	0.0243	0.0243	CcSEcCtD
Flumazenil—Shivering—Capecitabine—colon cancer	0.0243	0.0243	CcSEcCtD
Flumazenil—Depressed mood—Capecitabine—colon cancer	0.0202	0.0202	CcSEcCtD
Flumazenil—Speech disorder—Irinotecan—colon cancer	0.0157	0.0157	CcSEcCtD
Flumazenil—Vasodilation—Irinotecan—colon cancer	0.0154	0.0154	CcSEcCtD
Flumazenil—Vasodilation procedure—Irinotecan—colon cancer	0.0154	0.0154	CcSEcCtD
Flumazenil—Speech disorder—Fluorouracil—colon cancer	0.0151	0.0151	CcSEcCtD
Flumazenil—Supraventricular tachycardia—Capecitabine—colon cancer	0.0138	0.0138	CcSEcCtD
Flumazenil—Hiccups—Irinotecan—colon cancer	0.0135	0.0135	CcSEcCtD
Flumazenil—Salivary hypersecretion—Irinotecan—colon cancer	0.0131	0.0131	CcSEcCtD
Flumazenil—Tongue disorder—Capecitabine—colon cancer	0.0124	0.0124	CcSEcCtD
Flumazenil—Thrombophlebitis—Irinotecan—colon cancer	0.0113	0.0113	CcSEcCtD
Flumazenil—Deafness—Vincristine—colon cancer	0.0113	0.0113	CcSEcCtD
Flumazenil—Euphoric mood—Fluorouracil—colon cancer	0.0111	0.0111	CcSEcCtD
Flumazenil—Rigors—Capecitabine—colon cancer	0.0111	0.0111	CcSEcCtD
Flumazenil—Injection site pain—Capecitabine—colon cancer	0.0111	0.0111	CcSEcCtD
Flumazenil—Dysphonia—Capecitabine—colon cancer	0.011	0.011	CcSEcCtD
Flumazenil—Thrombophlebitis—Fluorouracil—colon cancer	0.0109	0.0109	CcSEcCtD
Flumazenil—Ventricular extrasystoles—Capecitabine—colon cancer	0.01	0.01	CcSEcCtD
Flumazenil—Hearing impaired—Capecitabine—colon cancer	0.00951	0.00951	CcSEcCtD
Flumazenil—Ataxia—Vincristine—colon cancer	0.00948	0.00948	CcSEcCtD
Flumazenil—Hiccups—Capecitabine—colon cancer	0.00905	0.00905	CcSEcCtD
Flumazenil—Stupor—Methotrexate—colon cancer	0.00903	0.00903	CcSEcCtD
Flumazenil—Injection site reaction—Capecitabine—colon cancer	0.009	0.009	CcSEcCtD
Flumazenil—Ataxia—Fluorouracil—colon cancer	0.00884	0.00884	CcSEcCtD
Flumazenil—Depressed level of consciousness—Capecitabine—colon cancer	0.00874	0.00874	CcSEcCtD
Flumazenil—Sweating increased—Irinotecan—colon cancer	0.00827	0.00827	CcSEcCtD
Flumazenil—Abnormal vision—Capecitabine—colon cancer	0.00789	0.00789	CcSEcCtD
Flumazenil—Speech disorder—Methotrexate—colon cancer	0.00783	0.00783	CcSEcCtD
Flumazenil—Thrombophlebitis—Capecitabine—colon cancer	0.00759	0.00759	CcSEcCtD
Flumazenil—Sweating—Vincristine—colon cancer	0.00745	0.00745	CcSEcCtD
Flumazenil—Deafness—Capecitabine—colon cancer	0.00735	0.00735	CcSEcCtD
Flumazenil—Sweating—Irinotecan—colon cancer	0.00725	0.00725	CcSEcCtD
Flumazenil—Hot flush—Capecitabine—colon cancer	0.00702	0.00702	CcSEcCtD
Flumazenil—Menopausal symptoms—Capecitabine—colon cancer	0.00696	0.00696	CcSEcCtD
Flumazenil—Hypoaesthesia—Vincristine—colon cancer	0.00694	0.00694	CcSEcCtD
Flumazenil—Hallucination—Vincristine—colon cancer	0.00694	0.00694	CcSEcCtD
Flumazenil—Bradycardia—Irinotecan—colon cancer	0.00691	0.00691	CcSEcCtD
Flumazenil—Diplopia—Capecitabine—colon cancer	0.00657	0.00657	CcSEcCtD
Flumazenil—Visual impairment—Irinotecan—colon cancer	0.00655	0.00655	CcSEcCtD
Flumazenil—Depressed level of consciousness—Methotrexate—colon cancer	0.00651	0.00651	CcSEcCtD
Flumazenil—Hypoaesthesia—Fluorouracil—colon cancer	0.00647	0.00647	CcSEcCtD
Flumazenil—Flushing—Irinotecan—colon cancer	0.0063	0.0063	CcSEcCtD
Flumazenil—Mood swings—Capecitabine—colon cancer	0.00622	0.00622	CcSEcCtD
Flumazenil—Ataxia—Capecitabine—colon cancer	0.00618	0.00618	CcSEcCtD
Flumazenil—Chills—Irinotecan—colon cancer	0.00609	0.00609	CcSEcCtD
Flumazenil—Arrhythmia—Irinotecan—colon cancer	0.00607	0.00607	CcSEcCtD
Flumazenil—Arrhythmia—Fluorouracil—colon cancer	0.00581	0.00581	CcSEcCtD
Flumazenil—Erythema—Fluorouracil—colon cancer	0.00566	0.00566	CcSEcCtD
Flumazenil—Thrombophlebitis—Methotrexate—colon cancer	0.00565	0.00565	CcSEcCtD
Flumazenil—Agitation—Vincristine—colon cancer	0.00558	0.00558	CcSEcCtD
Flumazenil—Sweating increased—Capecitabine—colon cancer	0.00553	0.00553	CcSEcCtD
Flumazenil—Ill-defined disorder—Irinotecan—colon cancer	0.00549	0.00549	CcSEcCtD
Flumazenil—Vertigo—Vincristine—colon cancer	0.00545	0.00545	CcSEcCtD
Flumazenil—Vision blurred—Fluorouracil—colon cancer	0.00534	0.00534	CcSEcCtD
Flumazenil—Malaise—Irinotecan—colon cancer	0.00533	0.00533	CcSEcCtD
Flumazenil—Vertigo—Irinotecan—colon cancer	0.00531	0.00531	CcSEcCtD
Flumazenil—Hypertension—Vincristine—colon cancer	0.00524	0.00524	CcSEcCtD
Flumazenil—Cough—Irinotecan—colon cancer	0.00516	0.00516	CcSEcCtD
Flumazenil—Hypertension—Irinotecan—colon cancer	0.0051	0.0051	CcSEcCtD
Flumazenil—Discomfort—Irinotecan—colon cancer	0.00497	0.00497	CcSEcCtD
Flumazenil—Confusional state—Irinotecan—colon cancer	0.00487	0.00487	CcSEcCtD
Flumazenil—Chest pain—Fluorouracil—colon cancer	0.00482	0.00482	CcSEcCtD
Flumazenil—Hyperhidrosis—Vincristine—colon cancer	0.00479	0.00479	CcSEcCtD
Flumazenil—Discomfort—Fluorouracil—colon cancer	0.00476	0.00476	CcSEcCtD
Flumazenil—Hyperhidrosis—Irinotecan—colon cancer	0.00466	0.00466	CcSEcCtD
Flumazenil—Confusional state—Fluorouracil—colon cancer	0.00466	0.00466	CcSEcCtD
Flumazenil—Mood swings—Methotrexate—colon cancer	0.00463	0.00463	CcSEcCtD
Flumazenil—Hypotension—Vincristine—colon cancer	0.00463	0.00463	CcSEcCtD
Flumazenil—Bradycardia—Capecitabine—colon cancer	0.00463	0.00463	CcSEcCtD
Flumazenil—Ataxia—Methotrexate—colon cancer	0.0046	0.0046	CcSEcCtD
Flumazenil—Hypoaesthesia—Capecitabine—colon cancer	0.00452	0.00452	CcSEcCtD
Flumazenil—Tachycardia—Fluorouracil—colon cancer	0.00451	0.00451	CcSEcCtD
Flumazenil—Hypotension—Irinotecan—colon cancer	0.00451	0.00451	CcSEcCtD
Flumazenil—Insomnia—Vincristine—colon cancer	0.00448	0.00448	CcSEcCtD
Flumazenil—Paraesthesia—Vincristine—colon cancer	0.00445	0.00445	CcSEcCtD
Flumazenil—Visual impairment—Capecitabine—colon cancer	0.00438	0.00438	CcSEcCtD
Flumazenil—Insomnia—Irinotecan—colon cancer	0.00436	0.00436	CcSEcCtD
Flumazenil—Paraesthesia—Irinotecan—colon cancer	0.00433	0.00433	CcSEcCtD
Flumazenil—Hypotension—Fluorouracil—colon cancer	0.00432	0.00432	CcSEcCtD
Flumazenil—Dyspnoea—Irinotecan—colon cancer	0.0043	0.0043	CcSEcCtD
Flumazenil—Somnolence—Irinotecan—colon cancer	0.00429	0.00429	CcSEcCtD
Flumazenil—Fatigue—Vincristine—colon cancer	0.00427	0.00427	CcSEcCtD
Flumazenil—Tinnitus—Capecitabine—colon cancer	0.00424	0.00424	CcSEcCtD
Flumazenil—Pain—Vincristine—colon cancer	0.00424	0.00424	CcSEcCtD
Flumazenil—Flushing—Capecitabine—colon cancer	0.00422	0.00422	CcSEcCtD
Flumazenil—Insomnia—Fluorouracil—colon cancer	0.00418	0.00418	CcSEcCtD
Flumazenil—Fatigue—Irinotecan—colon cancer	0.00416	0.00416	CcSEcCtD
Flumazenil—Paraesthesia—Fluorouracil—colon cancer	0.00415	0.00415	CcSEcCtD
Flumazenil—Pain—Irinotecan—colon cancer	0.00413	0.00413	CcSEcCtD
Flumazenil—Dyspnoea—Fluorouracil—colon cancer	0.00412	0.00412	CcSEcCtD
Flumazenil—Somnolence—Fluorouracil—colon cancer	0.00411	0.00411	CcSEcCtD
Flumazenil—Chills—Capecitabine—colon cancer	0.00408	0.00408	CcSEcCtD
Flumazenil—Arrhythmia—Capecitabine—colon cancer	0.00406	0.00406	CcSEcCtD
Flumazenil—Feeling abnormal—Irinotecan—colon cancer	0.00398	0.00398	CcSEcCtD
Flumazenil—Erythema—Capecitabine—colon cancer	0.00396	0.00396	CcSEcCtD
Flumazenil—Pain—Fluorouracil—colon cancer	0.00395	0.00395	CcSEcCtD
Flumazenil—Feeling abnormal—Fluorouracil—colon cancer	0.00381	0.00381	CcSEcCtD
Flumazenil—Drowsiness—Methotrexate—colon cancer	0.00377	0.00377	CcSEcCtD
Flumazenil—Vision blurred—Capecitabine—colon cancer	0.00373	0.00373	CcSEcCtD
Flumazenil—Tremor—Capecitabine—colon cancer	0.00371	0.00371	CcSEcCtD
Flumazenil—Ill-defined disorder—Capecitabine—colon cancer	0.00367	0.00367	CcSEcCtD
Flumazenil—Urticaria—Fluorouracil—colon cancer	0.00367	0.00367	CcSEcCtD
Flumazenil—Hypersensitivity—Vincristine—colon cancer	0.00365	0.00365	CcSEcCtD
Flumazenil—Sweating—Methotrexate—colon cancer	0.00361	0.00361	CcSEcCtD
Flumazenil—Malaise—Capecitabine—colon cancer	0.00357	0.00357	CcSEcCtD
Flumazenil—Vertigo—Capecitabine—colon cancer	0.00356	0.00356	CcSEcCtD
Flumazenil—Hypersensitivity—Irinotecan—colon cancer	0.00356	0.00356	CcSEcCtD
Flumazenil—Asthenia—Vincristine—colon cancer	0.00356	0.00356	CcSEcCtD
Flumazenil—Palpitations—Capecitabine—colon cancer	0.0035	0.0035	CcSEcCtD
Flumazenil—Asthenia—Irinotecan—colon cancer	0.00346	0.00346	CcSEcCtD
Flumazenil—Cough—Capecitabine—colon cancer	0.00345	0.00345	CcSEcCtD
Flumazenil—Hypertension—Capecitabine—colon cancer	0.00342	0.00342	CcSEcCtD
Flumazenil—Hypersensitivity—Fluorouracil—colon cancer	0.00341	0.00341	CcSEcCtD
Flumazenil—Chest pain—Capecitabine—colon cancer	0.00337	0.00337	CcSEcCtD
Flumazenil—Anxiety—Capecitabine—colon cancer	0.00336	0.00336	CcSEcCtD
Flumazenil—Discomfort—Capecitabine—colon cancer	0.00333	0.00333	CcSEcCtD
Flumazenil—Dry mouth—Capecitabine—colon cancer	0.00329	0.00329	CcSEcCtD
Flumazenil—Dizziness—Vincristine—colon cancer	0.00328	0.00328	CcSEcCtD
Flumazenil—Pruritus—Fluorouracil—colon cancer	0.00327	0.00327	CcSEcCtD
Flumazenil—Visual impairment—Methotrexate—colon cancer	0.00326	0.00326	CcSEcCtD
Flumazenil—Confusional state—Capecitabine—colon cancer	0.00326	0.00326	CcSEcCtD
Flumazenil—Dizziness—Irinotecan—colon cancer	0.00319	0.00319	CcSEcCtD
Flumazenil—Tinnitus—Methotrexate—colon cancer	0.00316	0.00316	CcSEcCtD
Flumazenil—Tachycardia—Capecitabine—colon cancer	0.00315	0.00315	CcSEcCtD
Flumazenil—Vomiting—Vincristine—colon cancer	0.00315	0.00315	CcSEcCtD
Flumazenil—Rash—Vincristine—colon cancer	0.00312	0.00312	CcSEcCtD
Flumazenil—Hyperhidrosis—Capecitabine—colon cancer	0.00312	0.00312	CcSEcCtD
Flumazenil—Dermatitis—Vincristine—colon cancer	0.00312	0.00312	CcSEcCtD
Flumazenil—Headache—Vincristine—colon cancer	0.0031	0.0031	CcSEcCtD
Flumazenil—Vomiting—Irinotecan—colon cancer	0.00307	0.00307	CcSEcCtD
Flumazenil—Dizziness—Fluorouracil—colon cancer	0.00306	0.00306	CcSEcCtD
Flumazenil—Rash—Irinotecan—colon cancer	0.00304	0.00304	CcSEcCtD
Flumazenil—Dermatitis—Irinotecan—colon cancer	0.00304	0.00304	CcSEcCtD
Flumazenil—Chills—Methotrexate—colon cancer	0.00304	0.00304	CcSEcCtD
Flumazenil—Headache—Irinotecan—colon cancer	0.00302	0.00302	CcSEcCtD
Flumazenil—Hypotension—Capecitabine—colon cancer	0.00302	0.00302	CcSEcCtD
Flumazenil—Erythema—Methotrexate—colon cancer	0.00295	0.00295	CcSEcCtD
Flumazenil—Nausea—Vincristine—colon cancer	0.00294	0.00294	CcSEcCtD
Flumazenil—Vomiting—Fluorouracil—colon cancer	0.00294	0.00294	CcSEcCtD
Flumazenil—Insomnia—Capecitabine—colon cancer	0.00292	0.00292	CcSEcCtD
Flumazenil—Rash—Fluorouracil—colon cancer	0.00291	0.00291	CcSEcCtD
Flumazenil—Dermatitis—Fluorouracil—colon cancer	0.00291	0.00291	CcSEcCtD
Flumazenil—Paraesthesia—Capecitabine—colon cancer	0.0029	0.0029	CcSEcCtD
Flumazenil—Headache—Fluorouracil—colon cancer	0.0029	0.0029	CcSEcCtD
Flumazenil—Dyspnoea—Capecitabine—colon cancer	0.00288	0.00288	CcSEcCtD
Flumazenil—Nausea—Irinotecan—colon cancer	0.00287	0.00287	CcSEcCtD
Flumazenil—Fatigue—Capecitabine—colon cancer	0.00278	0.00278	CcSEcCtD
Flumazenil—Vision blurred—Methotrexate—colon cancer	0.00278	0.00278	CcSEcCtD
Flumazenil—Pain—Capecitabine—colon cancer	0.00276	0.00276	CcSEcCtD
Flumazenil—Nausea—Fluorouracil—colon cancer	0.00275	0.00275	CcSEcCtD
Flumazenil—Ill-defined disorder—Methotrexate—colon cancer	0.00273	0.00273	CcSEcCtD
Flumazenil—Feeling abnormal—Capecitabine—colon cancer	0.00266	0.00266	CcSEcCtD
Flumazenil—Malaise—Methotrexate—colon cancer	0.00266	0.00266	CcSEcCtD
Flumazenil—Vertigo—Methotrexate—colon cancer	0.00265	0.00265	CcSEcCtD
Flumazenil—Cough—Methotrexate—colon cancer	0.00257	0.00257	CcSEcCtD
Flumazenil—Urticaria—Capecitabine—colon cancer	0.00257	0.00257	CcSEcCtD
Flumazenil—Chest pain—Methotrexate—colon cancer	0.00251	0.00251	CcSEcCtD
Flumazenil—Discomfort—Methotrexate—colon cancer	0.00248	0.00248	CcSEcCtD
Flumazenil—Confusional state—Methotrexate—colon cancer	0.00242	0.00242	CcSEcCtD
Flumazenil—Hypersensitivity—Capecitabine—colon cancer	0.00238	0.00238	CcSEcCtD
Flumazenil—Hyperhidrosis—Methotrexate—colon cancer	0.00232	0.00232	CcSEcCtD
Flumazenil—Asthenia—Capecitabine—colon cancer	0.00232	0.00232	CcSEcCtD
Flumazenil—Pruritus—Capecitabine—colon cancer	0.00228	0.00228	CcSEcCtD
Flumazenil—Hypotension—Methotrexate—colon cancer	0.00225	0.00225	CcSEcCtD
Flumazenil—Insomnia—Methotrexate—colon cancer	0.00217	0.00217	CcSEcCtD
Flumazenil—Paraesthesia—Methotrexate—colon cancer	0.00216	0.00216	CcSEcCtD
Flumazenil—Dyspnoea—Methotrexate—colon cancer	0.00214	0.00214	CcSEcCtD
Flumazenil—Somnolence—Methotrexate—colon cancer	0.00214	0.00214	CcSEcCtD
Flumazenil—Dizziness—Capecitabine—colon cancer	0.00214	0.00214	CcSEcCtD
Flumazenil—Fatigue—Methotrexate—colon cancer	0.00207	0.00207	CcSEcCtD
Flumazenil—Pain—Methotrexate—colon cancer	0.00206	0.00206	CcSEcCtD
Flumazenil—Vomiting—Capecitabine—colon cancer	0.00205	0.00205	CcSEcCtD
Flumazenil—Rash—Capecitabine—colon cancer	0.00204	0.00204	CcSEcCtD
Flumazenil—Dermatitis—Capecitabine—colon cancer	0.00203	0.00203	CcSEcCtD
Flumazenil—Headache—Capecitabine—colon cancer	0.00202	0.00202	CcSEcCtD
Flumazenil—Feeling abnormal—Methotrexate—colon cancer	0.00198	0.00198	CcSEcCtD
Flumazenil—Nausea—Capecitabine—colon cancer	0.00192	0.00192	CcSEcCtD
Flumazenil—Urticaria—Methotrexate—colon cancer	0.00191	0.00191	CcSEcCtD
Flumazenil—Hypersensitivity—Methotrexate—colon cancer	0.00177	0.00177	CcSEcCtD
Flumazenil—Asthenia—Methotrexate—colon cancer	0.00172	0.00172	CcSEcCtD
Flumazenil—Pruritus—Methotrexate—colon cancer	0.0017	0.0017	CcSEcCtD
Flumazenil—Dizziness—Methotrexate—colon cancer	0.00159	0.00159	CcSEcCtD
Flumazenil—Vomiting—Methotrexate—colon cancer	0.00153	0.00153	CcSEcCtD
Flumazenil—Rash—Methotrexate—colon cancer	0.00152	0.00152	CcSEcCtD
Flumazenil—Dermatitis—Methotrexate—colon cancer	0.00151	0.00151	CcSEcCtD
Flumazenil—Headache—Methotrexate—colon cancer	0.00151	0.00151	CcSEcCtD
Flumazenil—Nausea—Methotrexate—colon cancer	0.00143	0.00143	CcSEcCtD
